Companies: 10,795·Total market cap: $144.5T
Disc Medicine, Inc.

Disc Medicine, Inc.

IRONNASDAQHealthcare● Active
$65.71
$-1.29(-1.92%)
Market Cap$2.5B
P/E Ratio
52W High$99.5
52W Low$40
Overview

Disc Medicine, Inc. (IRON) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

iron · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Buy

11 analysts

consensus

Rating Breakdown

Strong Buy
1
Buy
10
Hold
0
Sell
0
Strong Sell
0
Total: 11 · Buy rate: 100.0%

12-Month Price Target

High

$125

Consensus

$101

+53.1% upside

Low

$80.00

Median: $100 · Last Close: $65.70

The Disc Medicine, Inc. (IRON) analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month IRON price target is $100.60, representing +53.1% upside from the current price of $65.70.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $101 (53.1%)

Consensus Target

$100.60

53.1% upside

High Target

$125

90.3%

Low Target

$80

21.8%

Current Price

$65.70

as of today

Based on analyst price targets, the IRON stock price prediction for the next 12 months ranges from $80 to $125. The consensus IRON price forecast of $100.60 implies 53.1% upside from the current price of $65.70.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$65.720.03%

1-day model range: $65.41–$66.02. Peak: $66.02 (+0.03%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$101+53.0%
2028$133+101.7%
2029$158+140.3%
2030$176+167.8%
2031+186.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%
1Buy
1Neutral
12Sell
RSI (14)47.8Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · IRON · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$68.43SELL
MA 10$69.24SELL
MA 20$68.43SELL
MA 50$67.77SELL
MA 100$68.09SELL
MA 200$72.80SELL
Current $IRON · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$67.98SELL
EMA 10$68.48SELL
EMA 20$68.41SELL
EMA 50$68.08SELL
EMA 100$69.02SELL
EMA 200$68.40SELL
Current $IRON · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Morgan Stanley2026-05-14
Maintains
OverweightOverweight
Wells Fargo2026-03-02
Maintains
OverweightOverweight
Truist Securities2026-02-27
Maintains
BuyBuy
Cantor Fitzgerald2026-02-17
Maintains
OverweightOverweight
BMO Capital2026-02-17
Maintains
OutperformOutperform
Wedbush2026-02-17
Maintains
OutperformOutperform
Wells Fargo2026-02-17
Maintains
OverweightOverweight
Stifel2026-02-17
Maintains
BuyBuy
Wells Fargo2025-12-16
Maintains
OverweightOverweight
Truist Securities2025-11-10
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Disc Medicine, Inc. (IRON) stock. Of the recent 69 rating actions, 2 were upgrades and 2 were downgrades. 11 analysts currently cover IRON.

Analyst Recommendation Trends

Buy ratings413
Hold ratings00
Sell ratings00

IRON analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$3M

↓ 97.7% YoY

Revenue Next Year

$32M

↑ 919.5% YoY

EPS This Year

$-6.94

EPS Next Year

$-7.42

↑ 6.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IRON EPS of $-6.94 for the current fiscal year, based on estimates from 9 analysts. The IRON revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The IRON stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IRON price target is $100.60 (+53.1% upside), with an analyst consensus of Buy.

The IRON short-term stock prediction for tomorrow is $65.72 (+0.03%). The IRON stock price prediction for 2027 estimates an average of $101. The IRON stock prediction for 2030 projects a range of $167–$185.

Disc Medicine, Inc. trades on NASDAQ under the ticker IRON. The IRON stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

IRON forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month IRON price target is $100.60, with a high forecast of $125.00 and a low of $80.00. The median price target is shown in the chart above when available. This implies +53.1% potential upside from the current price of $65.70.

IRON price targetWhat is IRON price targetIRON analyst price targetIRON 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.